Search Results - Yusuke Inoue
- Showing 1 - 5 results of 5
-
1
Knockout of the mitoribosome rescue factors Ict1 or Mtrfr is viable in zebrafish but not mice: compensatory mechanisms underlying each factor's loss by Nobukazu Nameki, Chika Tomisawa, Soichiro Hoshino, Hidehiko Shimizu, Masashi Abe, Sho Arai, Kanako Kuwasako, Naoki Asakawa, Yusuke Inoue, Takuro Horii, Izuho Hatada, Masakatsu Watanabe
Published 2025-08-01The mitochondrial translation system contains two ribosome rescue factors, ICT1 and MTRFR (C12orf65), which hydrolyze peptidyl‐tRNA in stalled ribosomes. ICT1 also functions as a ribosomal protein of the mitochondrial large ribosomal subunit (mtLSU) in mice and humans, and its deletion is lethal. In...
Get full text
Article -
2
Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab–sarotalocan sodium in a patient with oropharyngeal cancer: A case report by Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Published 2025-01-01Background: Photoimmunotherapy (PIT) using cetuximab–sarotalocan sodium (CS) is a novel therapy for unresectable or locally recurrent head and neck squamous cell carcinoma (HNSCC). CS is a conjugate of cetuximab (monoclonal antibody targeting epidermal growth factor receptor [EGFR]) and IR700 (light...
Get full text
Article -
3
First-line durvalumab plus platinum–etoposide in Japanese patients with extensive-stage small-cell lung cancer by Eisuke Mochizuki, Shun Matsuura, Naoki Koshimizu, Suguru Kojima, Shogo Sakurai, Satoshi Kishimoto, Mitsuru Niwa, Masayuki Watanuki, Ryunosuke Inaba, Sho Takuma, Yusuke Inoue, Masato Karayama, Naoki Inui, Takafumi Suda
Published 2025-01-01Background: Platinum-based chemotherapy combined with immune checkpoint inhibitor therapy has recently been introduced for treating extensive-stage small-cell lung cancer (ES-SCLC). In the Phase III CASPIAN study, first-line etoposide (Etoposide) with cisplatin / carboplatin (EP) plus durvalumab sig...
Get full text
Article -
4
Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal Lymphadenopathy by Hiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, Suguru Kojima, Keisuke Morikawa, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Naoki Inui, Sayaka Ishigaki, Naro Ohashi, Yasunori Enomoto, Satoshi Baba, Kazuhiro Tabata, Takeshi Johkoh, Takafumi Suda
Published 2025-07-01ABSTRACT We present a case of alveolar sarcoidosis showing lower lobe‐predominant areas of airspace consolidation and ground‐glass attenuation on HRCT, mimicking idiopathic interstitial pneumonia (IIP) with spontaneous wandering. Mediastinal lymphadenopathy and uveitis were negative. Surgical lung b...
Get full text
Article -
5
Late anastomotic complication after laparoscopic surgery for clinical stage I low rectal cancers located within 5 cm of the anal verge: Sub‐analysis of the ultimate trial by Manabu Shimomura, Masanori Yoshimitsu, Yuichiro Tsukada, Hideki Ohdan, Jun Watanabe, Yosuke Fukunaga, Yasumitsu Hirano, Kazuhiro Sakamoto, Hiroki Hamamoto, Hisanaga Horie, Nobuhisa Matsuhashi, Yoshiaki Kuriu, Shuntaro Nagai, Madoka Hamada, Shinichi Yoshioka, Shinobu Ohnuma, Tamuro Hayama, Koki Otsuka, Yusuke Inoue, Kazuki Ueda, Yuji Toiyama, Satoshi Maruyama, Shigeki Yamaguchi, Keitaro Tanaka, Motoko Suzuki, Toshihiro Misumi, Takeshi Naitoh, Masahiko Watanabe, Masaaki Ito, Ultimate Trial Group
Published 2025-07-01Abstract Background Although extensive research has been conducted on early anastomotic leakage (AL) after sphincter‐sparing surgery, the status of late anastomotic complications (post‐30 days) has received limited attention. These late complications significantly affect a patient's quality of...
Get full text
Article